{"nct_id":"NCT02337764","title":"A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2015-02-03","start_date_type":"ACTUAL","primary_completion_date":"2016-09-29","primary_completion_date_type":"ACTUAL","completion_date":"2016-09-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}